Curable metastatic colorectal cancer

Matthew J. Eadens, Axel F Grothey

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

In the United States and Europe, colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related death for men and women. In the course of their disease, many patients will present with metastasis, with the liver and lung being the most common locations. Untreated metastatic disease carries a poor prognosis. However, cure is still possible for selected patients with stage IV CRC. Surgical resection provides the best chance for cure, and chemotherapy can be a valuable adjunct when given in a (neo-)adjuvant fashion or as conversion therapy to downsize initially unresectable tumors. For unresectable metastases, alternative treatment options include radiofrequency ablation and hepatic artery infusion. Additional local therapies are being explored, including chemoembolization, radioembolization, and stereotactic body radiation therapy. Prospective randomized trials are needed to further clarify the roles of these novel treatment options in the clinician's repertoire for metastatic CRC.

Original languageEnglish (US)
Pages (from-to)168-176
Number of pages9
JournalCurrent Oncology Reports
Volume13
Issue number3
DOIs
StatePublished - Jun 2011

Fingerprint

Colorectal Neoplasms
Neoplasm Metastasis
Second Primary Neoplasms
Hepatic Artery
Therapeutics
Neoplasms
Radiotherapy
Drug Therapy
Lung
Liver

Keywords

  • Chemoembolization
  • Conversion therapy
  • Hepatic artery infusion
  • Hepatic metastases
  • Liver metastases
  • Lung metastases
  • Metastatic colorectal cancer
  • Neoadjuvant chemotherapy
  • Radioembolization
  • Radiofrequency ablation
  • Stereotactic body radiation therapy
  • Yttrium-90

ASJC Scopus subject areas

  • Oncology

Cite this

Curable metastatic colorectal cancer. / Eadens, Matthew J.; Grothey, Axel F.

In: Current Oncology Reports, Vol. 13, No. 3, 06.2011, p. 168-176.

Research output: Contribution to journalArticle

Eadens, Matthew J. ; Grothey, Axel F. / Curable metastatic colorectal cancer. In: Current Oncology Reports. 2011 ; Vol. 13, No. 3. pp. 168-176.
@article{15261b8e02d04551bf0bb1c5b5b556a4,
title = "Curable metastatic colorectal cancer",
abstract = "In the United States and Europe, colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related death for men and women. In the course of their disease, many patients will present with metastasis, with the liver and lung being the most common locations. Untreated metastatic disease carries a poor prognosis. However, cure is still possible for selected patients with stage IV CRC. Surgical resection provides the best chance for cure, and chemotherapy can be a valuable adjunct when given in a (neo-)adjuvant fashion or as conversion therapy to downsize initially unresectable tumors. For unresectable metastases, alternative treatment options include radiofrequency ablation and hepatic artery infusion. Additional local therapies are being explored, including chemoembolization, radioembolization, and stereotactic body radiation therapy. Prospective randomized trials are needed to further clarify the roles of these novel treatment options in the clinician's repertoire for metastatic CRC.",
keywords = "Chemoembolization, Conversion therapy, Hepatic artery infusion, Hepatic metastases, Liver metastases, Lung metastases, Metastatic colorectal cancer, Neoadjuvant chemotherapy, Radioembolization, Radiofrequency ablation, Stereotactic body radiation therapy, Yttrium-90",
author = "Eadens, {Matthew J.} and Grothey, {Axel F}",
year = "2011",
month = "6",
doi = "10.1007/s11912-011-0157-0",
language = "English (US)",
volume = "13",
pages = "168--176",
journal = "Current Oncology Reports",
issn = "1523-3790",
publisher = "Current Science, Inc.",
number = "3",

}

TY - JOUR

T1 - Curable metastatic colorectal cancer

AU - Eadens, Matthew J.

AU - Grothey, Axel F

PY - 2011/6

Y1 - 2011/6

N2 - In the United States and Europe, colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related death for men and women. In the course of their disease, many patients will present with metastasis, with the liver and lung being the most common locations. Untreated metastatic disease carries a poor prognosis. However, cure is still possible for selected patients with stage IV CRC. Surgical resection provides the best chance for cure, and chemotherapy can be a valuable adjunct when given in a (neo-)adjuvant fashion or as conversion therapy to downsize initially unresectable tumors. For unresectable metastases, alternative treatment options include radiofrequency ablation and hepatic artery infusion. Additional local therapies are being explored, including chemoembolization, radioembolization, and stereotactic body radiation therapy. Prospective randomized trials are needed to further clarify the roles of these novel treatment options in the clinician's repertoire for metastatic CRC.

AB - In the United States and Europe, colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related death for men and women. In the course of their disease, many patients will present with metastasis, with the liver and lung being the most common locations. Untreated metastatic disease carries a poor prognosis. However, cure is still possible for selected patients with stage IV CRC. Surgical resection provides the best chance for cure, and chemotherapy can be a valuable adjunct when given in a (neo-)adjuvant fashion or as conversion therapy to downsize initially unresectable tumors. For unresectable metastases, alternative treatment options include radiofrequency ablation and hepatic artery infusion. Additional local therapies are being explored, including chemoembolization, radioembolization, and stereotactic body radiation therapy. Prospective randomized trials are needed to further clarify the roles of these novel treatment options in the clinician's repertoire for metastatic CRC.

KW - Chemoembolization

KW - Conversion therapy

KW - Hepatic artery infusion

KW - Hepatic metastases

KW - Liver metastases

KW - Lung metastases

KW - Metastatic colorectal cancer

KW - Neoadjuvant chemotherapy

KW - Radioembolization

KW - Radiofrequency ablation

KW - Stereotactic body radiation therapy

KW - Yttrium-90

UR - http://www.scopus.com/inward/record.url?scp=79955880764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955880764&partnerID=8YFLogxK

U2 - 10.1007/s11912-011-0157-0

DO - 10.1007/s11912-011-0157-0

M3 - Article

C2 - 21298372

AN - SCOPUS:79955880764

VL - 13

SP - 168

EP - 176

JO - Current Oncology Reports

JF - Current Oncology Reports

SN - 1523-3790

IS - 3

ER -